Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study

被引:4868
|
作者
Go, AS
Hylek, EM
Phillips, KA
Chang, YC
Henault, LE
Selby, JV
Singer, DE
机构
[1] Kaiser Permanente No Calif, Div Res, Oakland, CA 94611 USA
[2] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[5] Massachusetts Gen Hosp, Dept Med, Div Gen Med, Clin Epidemiol Unit, Boston, MA 02114 USA
[6] Harvard Univ, Sch Med, Boston, MA USA
来源
关键词
Arrhythmia; Atrial fibrillation; Clinical cardiology (lauer ms; ed); Risk factors;
D O I
10.1001/jama.285.18.2370
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Atrial fibrillation is the most common arrhythmia in elderly persons and a potent risk factor for stroke. However, recent prevalence and projected future numbers of persons with atrial fibrillation are not well described. Objective To estimate prevalence of atrial fibrillation and US national projections of the numbers of persons with atrial fibrillation through the year 2050, Design, Setting, and Patients Cross-sectional study of adults aged 20 years or older who were enrolled in a large health maintenance organization in California and who had atrial fibrillation diagnosed between July 1, 1996, and December 31, 1997, Main Outcome Measures Prevalence of atrial fibrillation in the study population of 1.89 million; projected number of persons in the United States with atrial fibrillation between 1995-2050. Results A total of 17974 adults with diagnosed atrial fibrillation were identified during the study period; 45% were aged 75 years or older. The prevalence of atrial fibrillation was 0.95% (95% confidence interval, 0.94%-0.96%). Atrial fibrillation was more common in men than in women (1.1% vs 0.8%; P<.001). Prevalence increased from 0.1% among adults younger than 55 years to 9.0% in persons aged 80 years or older. Among persons aged 50 years or older, prevalence of atrial fibrillation was higher in whites than in blacks (2.2% vs 1.5%; P<.001). We estimate approximately 2.3 million US adults currently have atrial fibrillation. We project that this will increase to more than 5.6 million (lower bound, 5.0; upper bound, 6.3) by the year 2050, with more than 50% of affected individuals aged 80 years or older. Conclusions Our study confirms that atrial fibrillation is common among older adults and provides a contemporary basis for estimates of prevalence in the United States. The number of patients with atrial fibrillation is likely to increase 2.5-fold during the next 50 years, reflecting the growing proportion of elderly individuals. Coordinated efforts are needed to face the increasing challenge of optimal stroke prevention and rhythm management in patients with atrial fibrillation.
引用
收藏
页码:2370 / 2375
页数:6
相关论文
共 50 条
  • [1] Prevalence of atrial fibrillation: National implications for management and stroke prevention: The AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study
    Go, AS
    Hylek, EM
    Phillips, KA
    Henault, LE
    Selby, JV
    Singer, DE
    CIRCULATION, 1999, 100 (18) : 397 - 397
  • [2] Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation - The anticoagulation and risk factors in atrial fibrillation (ATRIA) study
    Go, AS
    Hylek, EM
    Phillips, KA
    Borowsky, LH
    Henault, LE
    Chang, YC
    Selby, JV
    Singer, DE
    CIRCULATION, 2000, 102 (01) : 11 - 13
  • [3] The impact of anticoagulation intensity on severity of stroke in atrial fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
    Hylek, EM
    Go, AS
    Chang, YC
    Phillips, KA
    Henault, LE
    Capra, AM
    Jensvold, NG
    Selby, JV
    Singer, DE
    CIRCULATION, 2002, 106 (19) : 577 - 578
  • [4] Predictors of warfarin use post stroke in atrial fibrillation: The AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study
    Hylek, EM
    Go, AS
    Chang, YC
    Phillips, KA
    Henault, LE
    Capra, AM
    Jensvold, NG
    Selby, JV
    Singer, DE
    CIRCULATION, 2002, 106 (19) : 727 - 728
  • [5] Utility of current stroke risk schemes in patients with atrial fibrillation: The AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study
    Fang, MC
    Go, AS
    Chang, YC
    Henault, LE
    Jensvold, NJ
    Singer, DE
    CIRCULATION, 2006, 113 (08) : E302 - E302
  • [6] Anticoagulation intensity and risk of stroke and intracranial hemorrhage in atrial fibrillation: The Anticoaguation and Risk Factors in Atrial Fibrillation (ATRIA) study
    Hylek, EM
    Go, AS
    Chang, YC
    Phillips, KA
    Henault, LE
    Selby, JV
    Singer, DE
    CIRCULATION, 2001, 104 (17) : 794 - 794
  • [7] Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation - The AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study
    Fang, MC
    Singer, DE
    Chang, YC
    Hylek, EM
    Henault, LE
    Jensvold, NG
    Go, AS
    CIRCULATION, 2005, 112 (12) : 1687 - 1691
  • [8] Factor v leiden mutation and risk of stroke in atrial fibrillation. The anticoagulation and risk factors in atrial fibrillation (ATRIA) study
    Go, AS
    Reed, GL
    Hylek, EM
    Phillips, KA
    Chang, Y
    Henault, LE
    Selby, JV
    Singer, DE
    CIRCULATION, 2001, 104 (17) : 530 - 530
  • [9] Factor V Leiden and Risk of Ischemic Stroke in Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
    Alan S. Go
    Guy L. Reed
    Elaine M. Hylek
    Kathleen A. Phillips
    MS Lin Liu
    Lori E. Henault
    Joe V. Selby
    Daniel E. Singer
    Journal of Thrombosis and Thrombolysis, 2003, 15 : 41 - 46
  • [10] Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study
    Go, AS
    Reed, GL
    Hylek, EM
    Phillips, KA
    Liu, L
    Henault, LE
    Selby, JV
    Singer, DE
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2003, 15 (01) : 41 - 46